Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
benzoylperoxid 50 mg + erythromycin 30 mg gel |
Is a |
Product containing benzoyl peroxide (medicinal product) |
false |
Inferred relationship |
Some |
|
|
benzoylperoxid 50 mg + erythromycin 30 mg gel |
Is a |
Product containing erythromycin (medicinal product) |
false |
Inferred relationship |
Some |
|
|
benzoylperoxid 50 mg + erythromycin 30 mg gel |
Is a |
erythromycin til topikal anvendelse |
false |
Inferred relationship |
Some |
|
|
benzoylperoxid 50 mg + erythromycin 30 mg gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Erythromycin (substance) |
false |
Inferred relationship |
Some |
|
|
benzoylperoxid 50 mg + erythromycin 30 mg gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Local anti-infective |
false |
Inferred relationship |
Some |
|
|
benzoylperoxid 50 mg + erythromycin 30 mg gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Benzoyl peroxide (substance) |
false |
Inferred relationship |
Some |
|
|
benzoylperoxid 50 mg + erythromycin 30 mg gel |
Is a |
Product containing benzoyl peroxide and erythromycin (medicinal product) |
false |
Inferred relationship |
Some |
|
|
benzoylperoxid 50 mg + erythromycin 30 mg gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Local anti-infective |
false |
Inferred relationship |
Some |
|
|
benzoylperoxid 50 mg + erythromycin 30 mg gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Baktericid |
false |
Inferred relationship |
Some |
|
|
benzoylperoxid 50 mg + erythromycin 30 mg gel |
Has manufactured dose form |
kutan OG/ELLER transdermal doseringsform |
false |
Inferred relationship |
Some |
|
|
benzoylperoxid 50 mg + erythromycin 30 mg gel |
Has manufactured dose form |
A semi-solid dose form consisting of a hydrophilic gel. |
false |
Inferred relationship |
Some |
|
|